Author

Alison L Hill

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 1

Frequent Co-Authors

Robert F Siliciano· 2 shared Timothy J Henrich· 2 shared Daniel I S Rosenbloom· 1 shared Daniel I.S. Rosenbloom· 1 shared Daniel R Kuritzkes· 1 shared Daniel Scholes Rosenbloom· 1 shared Dmitri A. Petrov· 1 shared Edward Goldstein· 1 shared

Activity by Year

2014-2016 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Robert F Siliciano

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV

Alison L Hill, Daniel Scholes Rosenbloom, Edward Goldstein, Emily Hanhauser, Daniel R Kuritzkes, Robert F Siliciano, Timothy J Henrich

This paper introduces mathematical and statistical models to predict HIV reservoir size and rebound time during ART interruption trials, showing that frequent sampling and sensitive assays are needed for reliable results.

PLOS Pathogens · Apr 27, 2016Peer-reviewedMicrobiology

Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for HIV-1

Daniel I S Rosenbloom, Oliver Elliott, Alison L Hill, Timothy J Henrich, Janet M Siliciano, Robert F Siliciano

The paper explains how to design and interpret limiting dilution assays for measuring HIV-1 latency, providing statistical methods and an online tool for frequency estimation.

bioRxiv · May 3, 2015Microbiology

Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multi-drug resistance

Stefany Moreno-Gamez, Alison L Hill, Daniel I.S. Rosenbloom, Dmitri A. Petrov, Martin A Nowak, Pleuni Pennings

The paper models how imperfect drug penetration creates spatial monotherapy, accelerating multi-drug resistance evolution in infections.

bioRxiv · Dec 19, 2014Evolutionary Biology